A spatial perturbation framework to validate implantation of the epileptogenic zone
 
				Authors: Jaber K,  Avigdor T,  Mansilla D,  Ho A,  Thomas J,  Abdallah C,  Chabardes S,  Hall J,  Minotti L,  Kahane P,  Grova C,  Gotman J,  Frauscher B
 
				
				
				
				Affiliations
				
					1 Analytical Neurophysiology Lab, Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada. 
 
 
 
 
 2 Department of Biomedical Engineering, Duke Pratt School of Engineering, Durham, NC, USA. 
 
 
 
 
 3 Multimodal Functional Imaging Lab, Biomedical Engineering Department, McGill University, Montréal, QC, Canada. 
 
 
 
 
 4 Neurophysiology Unit, Institute of Neurosurgery Dr. Asenjo, Santiago, Chile. 
 
 
 
 
 5 Department of Neurology, Duke University Medical Center, Durham, NC, USA. 
 
 
 
 
 6 Grenoble Institute Neurosciences, Inserm, U1216, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France. 
 
 
 
 
 7 Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada. 
 
 
 
 
 8 Multimodal Functional Imaging Lab, School of Health, Department of Physics, Concordia University, Montréal, QC, Canada. 
 
 
 
 
 9 Montreal Neurological Institute, McGill University, Montréal, QC, Canada. 
 
 
 
 
 10 Analytical Neurophysiology Lab, Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada. birgit.frauscher@duke.edu. 
 
 
 
 
 11 Department of Biomedical Engineering, Duke Pratt School of Engineering, Durham, NC, USA. birgit.frauscher@duke.edu. 
 
 
 
 
 12 Department of Neurology, Duke University Medical Center, Durham, NC, USA. birgit.frauscher@duke.edu. 
				
				
				
				Description
					
					Stereo-electroencephalography (SEEG) is the gold standard to delineate surgical targets in focal drug-resistant epilepsy. SEEG uses electrodes placed directly into the brain to identify the seizure-onset zone (SOZ). However, its major constraint is limited brain coverage, potentially leading to misidentification of the 'true' SOZ. Here, we propose a framework to assess adequate SEEG sampling by coupling epileptic biomarkers with their spatial distribution and measuring the system's response to a perturbation of this coupling. We demonstrate that the system's response is strongest in well-sampled patients when virtually removing the measured SOZ. We then introduce the spatial perturbation map, a tool that enables qualitative assessment of the implantation coverage. Probability modelling reveals a higher likelihood of well-implanted SOZs in seizure-free patients or non-seizure free patients with incomplete SOZ resections, compared to non-seizure-free patients with complete resections. This highlights the framework's value in sparing patients from unsuccessful surgeries resulting from poor SEEG coverage. 
				  
				
				
				
				Links
				PubMed: https://pubmed.ncbi.nlm.nih.gov/38897997/
 
				
					DOI: 10.1038/s41467-024-49470-z